---
title: "MJNY: Net loss of 674 million yuan in the first half of 2025"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253973809.md"
description: "MJNY announced that its operating revenue in the first half of 2025 was 8.245 billion yuan, a year-on-year decrease of 6.46%. The net loss attributable to shareholders of the listed company was 674 million yuan, compared to a net loss of 683 million yuan in the same period last year. The company plans not to distribute cash dividends, not to issue bonus shares, and not to increase capital through reserves"
datetime: "2025-08-21T11:07:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253973809.md)
  - [en](https://longbridge.com/en/news/253973809.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253973809.md)
generator: "portal-rs"
---

# MJNY: Net loss of 674 million yuan in the first half of 2025

MJNY announced that its operating revenue in the first half of 2025 is expected to be 8.245 billion yuan, a year-on-year decrease of 6.46%. The net loss attributable to shareholders of the listed company is 674 million yuan, compared to a net loss of 683 million yuan in the same period last year. The company plans not to distribute cash dividends, not to issue bonus shares, and not to increase capital through reserves

### Related Stocks

- [000723.CN](https://longbridge.com/en/quote/000723.CN.md)

## Related News & Research

- [Hyrox founders reclaim majority stake in fitness-racing group with L Catterton-led investors](https://longbridge.com/en/news/298426349.md)
- [TAL: Production exceeds targets and new royalty terms improve future economics](https://longbridge.com/en/news/298178519.md)
- [Climeworks says upgraded Mammoth units more than double CO₂ capture performance](https://longbridge.com/en/news/298546691.md)
- [Bioretec wins FDA 510(k) clearance for ActivaScrew Cannulated COM implant](https://longbridge.com/en/news/298552923.md)
- [ZAWYA: Nigeria, APM Terminals advance Badagry port plan to boost West Africa trade](https://longbridge.com/en/news/298418254.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**